Nuveen
PAND

Nuveen’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Nuveen’s Portfolio PAND Stock Details PAND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-52,760
Closed -$1.35M – 3657
2021
Q1 		$1.35M Buy
52,760
+23,238
+79% +$841K ﹤0.01% 2784
2020
Q4 		$438K Buy
29,522
+19,241
+187% +$268K ﹤0.01% 3070
2020
Q3 		$118K Buy
+10,281
New +$176K ﹤0.01% 3208

Nuveen's PAND Position: Q2 2021 in Review

Nuveen sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 52,760 shares — an estimated $1.35M sold.

Nuveen first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $1.35M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • Nuveen reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 52,760 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $1.35M.
  • Nuveen first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Nuveen's Pandion Therapeutics Inc. Common Stock position peaked at $1.35M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.